Week 3: DKA & HHS

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/19

encourage image

There's no tags or description

Looks like no tags are added yet.

20 Terms

1
New cards

Administration of Potassium

  • Infusion: Never give IV push; always dilute.

    • Push is given to prison for deaath penalty.

  • Dosage: Administer 10-20 mEq per hour.

  • Sample order: 40 mEq KCL in 500 mL D5W over 4 hours.

  • Preference for central line administration.


2
New cards

Pathophysiology of Diabetes

  • Affects carbohydrate, fat, and protein metabolism related to insulin and glucagon imbalances.

  • Both Type 1 and Type 2 diabetes are characterized by hyperglycemia.

  • These clients are very dehydrated.

    • The water is coming in and out because the glucose isn’t using it, thus this is why clients have polydipsia and polyuria.


3
New cards

Symptoms of Diabetes

  • Polydipsia (excessive thirst)

  • Polyuria (increased urination)

  • Polyphagia (increased hunger) due to alternative energy utilization (fat, then protein) when glucose is unavailable.


4
New cards

Type 1 Diabetes Characteristics

  • Accounts for <10% of all diabetics.

    • Autoimmune disease with viral triggers is primarily diagnosed in children and young adults.

    • Abrupt onset with weight loss; presence of urine ketones; no endogenous insulin production.

      • Glycolysis: the metabolic pathway that converts glucose into pyruvate, producing ATP and NADH, plays a crucial role in energy metabolism, particularly under conditions of insulin deficiency common in DKA.

      • Proteinloysis: The breakdown of proteins into amino acids occurs, leading to further metabolic complications in patients.

        • Both contribute to ketones in urine.


5
New cards

Type 2 Diabetes Characteristics

  • Most prevalent type (80-90% of diabetics).

    • Strong genetic component, often linked to obesity, predominantly occurs after age 45 (most common over age 65).

    • Insidious onset; insulin resistance developed; ketoacidosis is not typical.


6
New cards

Diabetic Ketoacidosis (DKA)

  • Acute Complication of Uncontrolled Diabetes

    • Fatal if left untreated.

    • Characterized by hyperglycemia, dehydration, electrolyte loss (K+ and Na), hyperkalemia, ketosis, and metabolic acidosis (only in DKA).

  • Primary Clinical Features

    • Presence of hyperglycemia, dehydration, hyperkalemia, ketosis, and metabolic acidosis.


7
New cards

Clinical Manifestations of DKA

  • Symptoms can be nonspecific and mistaken for other conditions:

    • Flushed, warm, and dry skin.

    • Lethargy and decreased level of consciousness (LOC).

    • Blurred vision.

    • Hypotension and tachycardia.

    • Severe abdominal pain, nausea, vomiting (GI upset with DKA due to the glycolysis going on).

    • Polyuria and polydipsia occurred 1-3 days prior.

    • Hyperventilation with Kussmaul respirations and fruity odor on breath (related to compensation for metabolic acidosis).


8
New cards

DKA Lab Findings

  • Serum glucose: 250-600 mg/dL

  • Serum potassium: can be high, low, or normal

  • Blood pH: 6.8-7.3

    • Give bicarbonate (IV push or drip) if the pH is less than 7.

  • Serum bicarbonate: <15 mEq/L

  • Serum sodium: 130-140 mEq/L

  • BUN: mildly elevated

  • Serum and urine ketones: increased.


9
New cards

Anion Gap Metabolic Acidosis

  • Serum anion gap is determined using the formula:

    • Serum sodium - (serum chloride + bicarbonate).

  • In DKA, the anion gap may be higher than 20 mEq/mL.

  • Normal is between 3-10.

    • Anything over 12 is considered a gap; consider metabolic acidosis.


10
New cards

Goals of DKA Management

  1. Correct fluid and electrolyte imbalances

  2. Provide adequate insulin for glucose metabolism

  3. Correct acidosis

  4. Prevent complications


11
New cards

Goal #1: Correct Fluid and Electrolye Imbalances

  • Initial IV fluid replacement with normal saline (NS) at a rate of 1 liter/hour until blood pressure stabilizes and urine output > 60 mL/hour.

    • May get 1 or more liters based on lab values.

  • After the first liter, switch to half normal saline at 300-500 mL/hour until glucose levels decrease.

  • When glucose is <250, change to D5 0.45% saline (hypertonic) to ensure continued insulin administration without hypoglycemia.

    • Once until <200-180, then the client can start eating and drinking.

  • Potassium Monitoring in DKA

    • Potassium levels: Initial high values expected due to movement out of cells.

    • Monitor serum K+ frequently post-hydration and insulin therapy initiation as levels can decline.


12
New cards

Goal #2: Provide Adequate Insulin

  • Initial IV bolus: 0.15 units/kg, followed by continuous infusion at 0.1 units/kg.

  • Monitor blood glucose every hour; if no change after 1 hr, double the infusion rate.

    • Prevent a decrease in glucose by more than 50-100 mg/hour to avoid complications such as cerebral edema.

  • Upon blood glucose <250 mg/dL, reduce insulin infusion by half and switch to sliding scale therapy.

    • Sliding scale while still on the drip to prevent rebound hyperglycemia and maintain stable glucose levels.


13
New cards

Goal #3: Correct Acidosis

  • Routine bicarbonate administration is not advised; acidosis resolves with insulin’s action.

  • If pH < 7.0, a slow IV infusion of bicarbonate may be given over several hours.


14
New cards

Goal #4: Prevent Complications

  • Monitor and promptly address:

    • Cardiac arrhythmias.

    • Electrolyte imbalances (hyper/hypokalemia).

    • Cerebral and pulmonary edema.

    • Hypoglycemia.

    • Acute renal failure.


15
New cards

Patient Teaching for DKA

  • Emphasize adherence to treatment regimens, especially during illness:

    • Do not stop insulin/hypoglycemic agents when sick (sick day rules).

      • Prioritizing hydration and checking sugar more often.

    • Maintain oral intake of fluids and carbohydrates.

    • Check blood glucose and ketones every 4 hours.

    • Contact healthcare provider if unable to take PO or if urine ketones are positive or BG is elevated.


16
New cards

Hyperglycemia Hyperosmolar Syndrome (HHS)

  • Higher mortality rate than DKA (20-40%).

  • Gradual onset over days to weeks (DKA occurs within a few hours).

  • Hallmarks: Severe hyperglycemia, profound dehydration, and lack of ketosis.

    • No change in pH.

    • Occurs more likely in Type 2, especially in those who don’t drink water.

  • Etiology and Pathophysiology

    • More common in type II diabetics, frequently triggered by illness or stress.

    • Most prevalent in older, obese diabetics with impaired thirst and decreased renal function.

    • May also occur in patients previously undiagnosed with diabetes, sometimes precipitated by medications like steroids or thiazides.


17
New cards

HHS Difference from DKA

  • No ketonuria, as the patient retains some insulin secretion.

  • Despite insulin secretion, glucose transport into cells is inadequate, leading to hyperglycemia.


18
New cards

HHS Clinical Manifestations

  • Gradual symptom onset (you’d notice more signs of dehydration):

    • Polydipsia, polyuria, sugar cravings.

    • Weight loss, dry mucous membranes, poor skin turgor, pallor.

    • Weakness, fatigue, lethargy, coma.

    • Hypotension, tachycardia.

    • Dyspnea without fruity breath.

    • Mild abdominal pain.


19
New cards

HHS Laboratory Findings

  • Serum glucose: 600-2000 mg/dL.

  • Serum ketones: normal or mildly elevated.

  • Serum pH: normal or mild acidosis (pH > 7.25).

  • Serum Na+: normal or elevated.

  • Bicarbonate: normal.

  • Serum K+: normal, low, or elevated.

  • BUN: >80 mg/dL.

    • Higher chance of kidney injury due to fluid imbalances.

  • Serum osmolality: >400 (normal 285-295).


20
New cards

Nursing Care for HHS

  • Primary Intervention: Rapid rehydration, with deficits potentially exceeding 10 liters.

    • Administer NS 2L during the first hour, followed by D5 0.45% saline for the next 6-10L.

    • When glucose reaches 250-300 mg/dL, switch to D5 1/2 NS.

  • IV Insulin Administration

    • Low-dose insulin to facilitate cellular glucose uptake and decrease serum osmolality.

    • Potassium Replacement: Needed as rehydration occurs; however, loss is generally less than in DKA.

    • Bicarbonate therapy is not necessary in HHS management.